Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Pharmaceutical Preparations

https://www.tevapharm.com

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

5 BAZEL ST, P O B 3190
PETACH TIKVA, L3

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/26/1990

Market Cap

20,654,294,401

Shares Outstanding

1,120,970,000

Weighted SO

1,120,971,202

Total Employees

N/A

Upcoming Earnings

07/31/2024

Similar Tickers

HLN --.--%

BHC --.--%

ZTS --.--%

TAK --.--%

ELAN --.--%

VTRS --.--%

CTLT --.--%

MNK --.--%

Beta

0.9010

Last Div

0.0000

Range

8.06-18.58

Chg

-0.1001

Avg Vol

9304304

Mkt Cap

20654294401

Exch

NYSE

Country

IL

Phone

972 3 914 8213

DCF Diff

21.1896

DCF

-2.9737

Div Yield

0.0000

P/S

1.2671

EV Multiple

8.2985

P/FV

3.2481

Div Yield %

0.0000

P/E

-43.4831

PEG

-0.5690

Payout

0.0000

Current Ratio

0.8922

Quick Ratio

0.5910

Cash Ratio

0.1732

DSO

84.3255

DIO

174.2045

Op Cycle

258.5300

DPO

104.9575

CCC

153.5726

Gross Margin

0.4952

Op Margin

0.1562

Pretax Margin

-0.0101

Net Margin

-0.0291

Eff Tax Rate

-3.6788

ROA

-0.0115

ROE

-0.0677

ROCE

0.0900

NI/EBT

2.8788

EBT/EBIT

-0.0648

EBIT/Rev

0.1562

Debt Ratio

0.4509

D/E

2.9314

LT Debt/Cap

0.7224

Total Debt/Cap

0.7456

Int Coverage

3.3915

CF/Debt

0.0955

Equity Multi

6.5007

Rec Turnover

4.3285

Pay Turnover

3.4776

Inv Turnover

2.0952

FA Turnover

2.7484

Asset Turnover

0.3943

OCF/Share

1.5711

FCF/Share

1.1395

Cash/Share

1.9929

OCF/Sales

0.1092

FCF/OCF

0.7253

CF Coverage

0.0955

ST Coverage

0.8500

CapEx Coverage

3.6401

Div&CapEx Cov

3.6401

P/BV

3.2481

P/B

3.2481

P/S

1.2671

P/E

-43.4831

P/FCF

15.9987

P/OCF

11.6036

P/CF

11.6036

PEG

-0.5690

P/S

1.2671

EV Multiple

8.2985

P/FV

3.2481

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 31, 01:05 New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025 GlobeNewswire Inc. May 31, 01:00 Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T The Motley Fool Feb 16, 14:45 This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy? GlobeNewswire Inc. Jan 14, 03:26 Teva gibt Zusammenarbeit zur Vermarktung des Formycon Biosimilar-Kandidaten für Eylea® (Aflibercept) in großen Teilen Europas und in Israel bekannt GlobeNewswire Inc. Jan 14, 03:26 Teva annonce un partenariat en vue de commercialiser le candidat biosimilaire de Formycon à Eylea® (aflibercept) dans la majeure partie de l’Europe et en Israël GlobeNewswire Inc. Aug 26, 00:30 Global Acetaminophen-Opioid Combination Market Growth Accelerating Due to an Impressive USD 4,522.6 Million by 2034 Increased Usage in Cancer-Related Pain: Future Market Insights Benzinga Jul 06, 16:15 DeSantis Is Less Popular Than Florida's Cannabis Amendment, Wealthy Attorney John Morgan Eyes Gubernatorial Run - Benzinga GlobeNewswire Inc. Jul 03, 05:00 Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewswire Benzinga Jan 23, 07:44 Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday The Motley Fool Jan 10, 05:21 3 No-Brainer Stocks to Buy With $20 Right Now The Motley Fool Dec 15, 05:21 My 5 Largest Portfolio Holdings for 2024 Benzinga Nov 27, 16:35 Israel And Hamas Agree To Extend Truce By 2 Days; Elon Musk Wishes For World Peace After Visiting Israel Benzinga Nov 27, 16:35 Israel, Hamas Agree To Extend Truce By 2 Days; Elon Musk Wishes For World Peace After Visiting Israel Benzinga Nov 27, 12:00 What To Know About UBS's Upgrade of Teva Pharmaceutical Indus Benzinga Nov 27, 07:22 CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday The Motley Fool Nov 08, 14:15 Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript Benzinga Nov 08, 13:26 US Stocks Set To Snap Winning Streak, Treasuries Rally, Oil Tumbles: What's Driving Markets Wednesday?

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.08 11/27/2017 11/02/2017 11/28/2017 12/12/2017
0.08 08/25/2017 08/04/2017 08/29/2017 09/14/2017
0.34 06/01/2017 05/16/2017 06/05/2017 06/22/2017
0.34 02/28/2017 02/13/2017 03/02/2017 03/20/2017
0.34 12/01/2016 11/17/2016 12/05/2016 12/20/2016
0.34 08/18/2016 08/08/2016 08/22/2016 09/08/2016
0.34 05/20/2016 05/11/2016 05/24/2016 06/07/2016
0.34 02/25/2016 02/16/2016 02/29/2016 03/14/2016
0.34 11/13/2015 11/02/2015 11/17/2015 12/03/2015
0.34 08/18/2015 07/31/2015 08/20/2015 09/03/2015
0.34 05/15/2015 05/05/2015 05/19/2015 06/04/2015
0.34 02/17/2015 02/20/2015 02/19/2015 03/03/2015
0.32 11/13/2014 10/31/2014 11/17/2014 12/02/2014
0.35 08/19/2014 08/01/2014 08/21/2014 09/04/2014
0.35 05/16/2014 05/02/2014 05/20/2014 06/02/2014
0.34 02/20/2014 02/04/2014 02/24/2014 03/10/2014
0.33 11/18/2013 11/21/2013 11/20/2013 12/03/2013
0.32 08/16/2013 08/05/2013 08/20/2013 09/03/2013
0.32 05/16/2013 05/06/2013 05/20/2013 06/03/2013
0.31 02/19/2013 02/08/2013 02/21/2013 03/07/2013
0.26 11/13/2012 11/30/-0001 11/30/-0001 12/03/2012
0.25 08/13/2012 11/30/-0001 11/30/-0001 09/04/2012
0.26 05/17/2012 11/30/-0001 11/30/-0001 06/04/2012
0.27 02/23/2012 11/30/-0001 11/30/-0001 11/30/-0001
0.22 11/09/2011 11/30/-0001 11/30/-0001 12/07/2011
0.24 08/04/2011 11/30/-0001 11/30/-0001 08/25/2011
0.23 05/19/2011 11/30/-0001 11/30/-0001 06/07/2011
0.22 02/10/2011 11/30/-0001 11/30/-0001 03/07/2011
0.19 11/08/2010 11/30/-0001 11/30/-0001 12/06/2010
0.18 08/02/2010 11/30/-0001 11/30/-0001 08/26/2010
0.19 05/10/2010 11/30/-0001 11/30/-0001 11/30/-0001
0.19 02/19/2010 11/30/-0001 11/30/-0001 11/30/-0001
0.16 11/06/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.15 08/03/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.14 05/08/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.15 02/23/2009 11/30/-0001 11/30/-0001 11/30/-0001
0.12 11/07/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.13 08/01/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.13 05/13/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.12 02/15/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.10 11/02/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.09 08/10/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.10 05/10/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.09 02/16/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.08 11/10/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.08 08/11/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.08 05/12/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.07 03/06/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.06 11/10/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.07 08/11/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.07 05/05/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.07 02/17/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.05 11/09/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.05 08/09/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.10 05/10/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.10 02/20/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.07 11/13/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.08 08/08/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.07 05/08/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.07 02/24/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.04 01/07/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.09 11/07/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.09 08/19/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.09 05/20/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.09 02/15/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.06 11/16/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.06 08/20/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.06 05/17/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.07 03/08/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.06 11/16/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.06 08/24/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.05 05/19/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.05 11/04/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.06 08/18/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.06 05/21/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.06 03/08/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.06 11/20/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.06 11/16/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.06 08/21/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.06 05/21/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.07 03/12/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.07 11/20/1997 11/30/-0001 11/30/-0001 11/30/-0001
0.07 08/25/1997 11/30/-0001 11/30/-0001 11/30/-0001
0.06 05/23/1997 11/30/-0001 11/30/-0001 11/30/-0001
0.05 03/07/1997 11/30/-0001 11/30/-0001 11/30/-0001
0.05 11/20/1996 11/30/-0001 11/30/-0001 11/30/-0001
0.05 08/26/1996 11/30/-0001 11/30/-0001 11/30/-0001
0.05 05/23/1996 11/30/-0001 11/30/-0001 11/30/-0001
0.05 03/07/1996 11/30/-0001 11/30/-0001 11/30/-0001
0.05 11/20/1995 11/30/-0001 11/30/-0001 11/30/-0001
0.05 08/14/1995 11/30/-0001 11/30/-0001 11/30/-0001
0.06 05/17/1995 11/30/-0001 11/30/-0001 11/30/-0001
0.05 03/07/1995 11/30/-0001 11/30/-0001 11/30/-0001
0.05 11/15/1994 11/30/-0001 11/30/-0001 11/30/-0001
0.05 08/09/1994 11/30/-0001 11/30/-0001 11/30/-0001
0.04 03/08/1994 11/30/-0001 11/30/-0001 11/30/-0001
0.04 11/17/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.04 08/17/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.04 05/18/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.04 04/07/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.04 11/17/1992 11/30/-0001 11/30/-0001 11/30/-0001
0.05 08/18/1992 11/30/-0001 11/30/-0001 11/30/-0001
0.04 05/19/1992 11/30/-0001 11/30/-0001 11/30/-0001
0.04 03/03/1992 11/30/-0001 11/30/-0001 11/30/-0001
0.04 11/20/1991 11/30/-0001 11/30/-0001 11/30/-0001
0.04 08/21/1991 11/30/-0001 11/30/-0001 11/30/-0001
0.04 05/20/1991 11/30/-0001 11/30/-0001 11/30/-0001
0.04 03/05/1991 11/30/-0001 11/30/-0001 11/30/-0001
0.04 11/20/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.04 08/17/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.04 05/21/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.04 03/08/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.03 11/20/1989 11/30/-0001 11/30/-0001 11/30/-0001
0.03 08/16/1989 11/30/-0001 11/30/-0001 11/30/-0001
0.03 05/22/1989 11/30/-0001 11/30/-0001 11/30/-0001
0.04 03/09/1989 11/30/-0001 11/30/-0001 11/30/-0001
0.03 12/06/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.04 09/08/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.03 06/10/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.03 04/12/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.03 02/08/1988 11/30/-0001 11/30/-0001 11/30/-0001
0.03 10/23/1987 11/30/-0001 11/30/-0001 11/30/-0001
0.04 07/09/1987 11/30/-0001 11/30/-0001 11/30/-0001
0.03 06/22/1987 11/30/-0001 11/30/-0001 11/30/-0001
0.03 02/23/1987 11/30/-0001 11/30/-0001 11/30/-0001